BPS Bioscience 品牌
生产厂家厂商性质
所在地
ATAT1, GST-tag Recombinant
面议ATF2, GST-Tag Recombinant
面议GCN5 (727-837), His-tag Recombinant
面议GCN5 (KAT2A), FLAG-tag Recombinant
面议p300 (KAT3B), His-GST-tag Recombinant
面议ACHE, His-Tag Recombinant
面议APAF1, His-tag, FLAG-tag Recombinant
面议BCL-2, His-Tag Recombinant
面议BCL2A1, His-Tag Recombinant
面议BCL2L10, His-Tag Recombinant
面议Caspase6, His-tag Recombinant
面议Caspase7, His-tag Recombinant
面议Recombinant HEK293 cell line expressing human PDE7A (phosphodiesterase 7A, accession number NM_002603).
N-terminal FLAG-tagged human PDE7A has been stably expressed in a human embryonic kidney (HEK293) cell line. PDE7A expression was confirmed by Western blotting. The regulation of intracellular level of cAMP by PDE7A in PDE7A stably-expressed HEK293 cells was characterized by a cell-based reporter assay using pCRE-luc reporter vector. pCRE-luc contains a luciferase gene that is under the control of the cAMP response element (CRE). When cells transiently transfected with pCRE-luc reporter were activated by forskolin, the level of cAMP was upregulated in parental HEK293 cells, inducing the expression of the luciferase reporter, whereas hPDE7A-HEK293 cells showed reduction in the level of cAMP that resulted in lowered expression of luciferase. Inhibition of PDE7A activity by BRL 50481, a PDE7A inhibitor, restored the cAMP level, resulting in higher luciferase activity.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.